Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancer

被引：0
|
作者：
Xia Xu
Fei Deng
Mengmeng Lv
Binhui Ren
Wenwen Guo
Xiaoxiang Chen
机构：
[1] Department of Chemotherapy,
[2] Jiangsu Cancer Hospital,undefined
[3] Department of Gynecologic Oncology,undefined
[4] Jiangsu Cancer Hospital,undefined
[5] Department of Thoracic Oncology,undefined
[6] Jiangsu Cancer Hospital,undefined
[7] The Second Affiliated Hospital of Nanjing Medical University,undefined
来源：
Journal of Ovarian Research | / 9卷
关键词：
High grade serous ovarian cancer; CA-125; Ascites; Primary debulking surgery; Interval debulking surgery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Does the method of primary treatment affect the pattern of first recurrence in high-grade serous ovarian cancer?
    Himoto, Yuki
    Cybulska, Paulina
    Shitano, Fuki
    Sala, Evis
    Zheng, Junting
    Capanu, Marinela
    Nougaret, Stephanie
    Nikolovski, Ines
    Vargas, Hebert A.
    Wang, Wei
    Mueller, Jennifer J.
    Chi, Dennis S.
    Lakhman, Yulia
    GYNECOLOGIC ONCOLOGY, 2019, 155 (02) : 192 - 200
  • [42] Expression of programmed cell death ligand 1 and immune checkpoint markers in residual tumors after neoadjuvant chemotherapy for advanced high-grade serous ovarian cancer
    Kim, Hyun-Soo
    Kim, Ji-Ye
    Lee, Yong Jae
    Kim, So Hee
    Lee, Jung-Yun
    Nam, Eun Ji
    Kim, Sunghoon
    Kim, Sang Wun
    Kim, Young Tae
    GYNECOLOGIC ONCOLOGY, 2018, 151 (03) : 414 - 421
  • [43] Laparoscopic Cytoreduction After Neoadjuvant Chemotherapy in High-Grade Epithelial Ovarian Cancer A LANCE Randomized Clinical Trial
    Rauh-Hain, J. Alejandro
    Melamed, Alexander
    Pareja, Rene
    May, Taymaa
    Sinno, Abdulrahman
    Mcnally, Leah
    Horowitz, Neil S.
    De Iaco, Pierandrea
    Michener, Chad M.
    Van Lonkhuijzen, Luc
    Iniesta, Maria D.
    Yuan, Ying
    Ramirez, Pedro T.
    Fagotti, Anna
    JAMA NETWORK OPEN, 2024, 7 (11)
  • [44] High HOXA9 gene expression predicts response to chemotherapy and prognosis of high-grade serous ovarian cancer patients
    Li, Xiao-fei
    Zhang, Hai-Bo
    Huo, Yan
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2022, 50 (11)
  • [45] Size distribution of extracellular vesicles in pretreatment ascites and plasma is correlated with primary treatment outcome in advanced high-grade serous carcinoma
    Herzog, Marusa
    Verdenik, Ivan
    Kobal, Borut
    Cerne, Katarina
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [46] Preoperative prediction of miliary changes in the small bowel mesentery in advanced high-grade serous ovarian cancer using MRI radiomics nomogram
    Qinhao Guo
    Zijing Lin
    Jing Lu
    Rong Li
    Lei Wu
    Lin Deng
    Jinwei Qiang
    Xiaohua Wu
    Yajia Gu
    Haiming Li
    Abdominal Radiology, 2023, 48 : 1119 - 1130
  • [47] Potential Transcriptomic Biomarkers for Predicting Platinum-based Chemotherapy Resistance in Patients With High-grade Serous Ovarian Cancer
    Cocchi, Sara
    Lopacinska-Jorgensen, Joanna
    Hogdall, Estrid, V
    ANTICANCER RESEARCH, 2024, 44 (11) : 4691 - 4707
  • [48] Preoperative prediction of miliary changes in the small bowel mesentery in advanced high-grade serous ovarian cancer using MRI radiomics nomogram
    Guo, Qinhao
    Lin, Zijing
    Lu, Jing
    Li, Rong
    Wu, Lei
    Deng, Lin
    Qiang, Jinwei
    Wu, Xiaohua
    Gu, Yajia
    Li, Haiming
    ABDOMINAL RADIOLOGY, 2023, 48 (03) : 1119 - 1130
  • [49] Construction of an aging-related risk signature in high-grade serous ovarian cancer for predicting survival outcome and immunogenicity
    Liu, Suxia
    Liu, Yuexia
    Ma, Jianhong
    Lv, Rou
    Wang, Fang
    MEDICINE, 2023, 102 (35) : E34851
  • [50] Potential utility of pretreatment serum miRNAs for optimal treatment selection in advanced high-grade serous ovarian cancer
    Uehara, Takashi
    Matsuzaki, Juntaro
    Yoshida, Hiroshi
    Ogawa, Yuto
    Miura, Junichiro
    Fujimiya, Hitoshi
    Yamamoto, Yusuke
    Kawauchi, Junpei
    Takizawa, Satoko
    Yonemori, Kan
    Sakamoto, Hiromi
    Kato, Ken
    Ishikawa, Mitsuya
    Ochiya, Takahiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (08) : 917 - 925
12345